Article
Mesenchymal stem cells ameliorate inflammation in an experimental model of Crohn’s disease via the mesentery
2023-05-24
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Objective</h4> Mesenchymal stem cells (MSCs) are novel therapeutics for treatment of Crohn’s disease. However, their mechanism of action is unclear, especially in disease-relevant chronic models of inflammation. Thus, we used SAMP-1/YitFc, a chronic and spontaneous murine model of small intestinal inflammation, to study the therapeutic effect and mechanism of human bone marrow-derived MSCs...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ed8d7b4c-1066-57ee-b6c6-4271da73c90e
- DOI
- 10.1101/2023.05.22.541829
